Form RI-7695E (Research & Development Expense Credit)

Form RI-7695E is the state tax document used to calculate the Rhode Island Research and Development Expense Credit for qualified research costs incurred within the state. It enables eligible businesses to reduce their tax liability by applying tiered rates to incremental research spending that exceeds a federally defined base amount.

The Rhode Island Research and Development (R&D) Expense Credit, codified under R.I. Gen. Laws § 44-32-3, serves as a pivotal fiscal instrument designed to incentivize high-technology investment and intellectual property development within the state’s borders. By aligning state tax benefits with the rigorous standards of the Internal Revenue Code (IRC) Section 41, Rhode Island provides a robust framework for corporations and pass-through entities to recapture a portion of their investment in innovation. However, the state’s specific implementation—characterized by tiered credit rates, a strict geographic nexus, and unique ordering rules—requires a nuanced understanding of both the statutory language and the administrative guidance issued by the Rhode Island Division of Taxation. Form RI-7695E acts as the primary conduit for this benefit, requiring taxpayers to distill global research activities into state-specific expenditures while navigating complex limitations related to tax liability caps and corporate minimums.

Statutory Framework and Legislative Evolution

The authority for the Rhode Island R&D Expense Credit is established in Title 44, Chapter 32 of the General Laws. Section 44-32-3 provides that a taxpayer shall be allowed a credit against the tax imposed by chapters 11 (Business Corporation Tax), 17 (Tax on Financial Institutions), and 30 (Personal Income Tax). The legislative history of this provision reflects a strategic shift in the state’s economic policy that occurred in the late 1990s. Prior to January 1, 1998, the credit was set at a flat rate of five percent of the excess qualified research expenses.

Recognizing the need to remain competitive with neighboring Massachusetts and Connecticut, the Rhode Island General Assembly dramatically increased the incentive structure for tax years beginning on or after January 1, 1998. The current tiered system was introduced to provide a more aggressive credit for the first tranche of research spending, thereby favoring small-to-medium-sized enterprises and early-stage technology firms. The statute defines the credit amount as 22.5% for the first $25,000 of the credit (not the expense), and 16.9% for the portion of the credit exceeding $25,000. In practical terms, as reflected on Form RI-7695E, this translates to a 22.5% rate on the first $111,111 of qualified excess expenditures and 16.9% on expenditures above that threshold.

The 1994 Commencement Date

A critical temporal constraint found throughout the statute and the instructions for Form RI-7695E is the date of July 1, 1994. The law stipulates that expenses must have been incurred in Rhode Island after this date to qualify for the credit. This historical marker signifies the original implementation of the R&D incentive package, and it continues to govern the “base period” calculations for older entities. For modern practitioners, this date serves as the floor for determining which historical records are relevant for state-level audits and for establishing the RI-specific portion of the federal excess.

Detailed Analysis of Qualified Research Expenses (QREs)

Rhode Island largely relies on the federal definitions provided in 26 U.S.C. § 41 to determine what constitutes “qualified research.” This federal-state nexus is essential for administrative efficiency, as it allows the Rhode Island Division of Taxation to leverage federal audit standards and definitions. However, the state applies a strict geographic “situs” requirement that is not present at the federal level.

The Four-Part Test for Innovation

To qualify for the Rhode Island credit, an activity must meet the four criteria established by the IRC, which are incorporated into the state’s regulatory guidance under 280-RICR-20-20-2. The research must first be technological in nature, meaning it fundamentally relies on the principles of engineering, computer science, biological science, or physical science. Second, the research must be for a “permitted purpose,” which is defined as the development of a new or improved business component. A business component can be a product, process, computer software, technique, formula, or invention.

The third and fourth components of the test address the technical uncertainty of the project. The activity must be intended to discover information that would eliminate uncertainty regarding the capability, method, or appropriate design for developing or improving the business component. Finally, the taxpayer must engage in a systematic process of experimentation, which typically involves evaluating one or more alternatives through modeling, simulation, or trial-and-error.

Exclusions from Qualification

Both the statute (§ 44-32-2 and § 44-32-3) and the Division of Taxation guidance explicitly list activities that do not qualify as research and development in the “experimental or laboratory sense.” These exclusions are designed to prevent the credit from being applied to routine business operations or soft-science research.

Excluded Activity Type	Statutory Basis	Administrative Interpretation
Quality Control	§ 44-32-2(b)	Ordinary testing or inspection of materials/products.
Management Studies	§ 44-32-2(b)	Efficiency surveys and organizational research.
Consumer Surveys	§ 44-32-2(b)	Market research and advertising/promotion studies.
Social Sciences	§ 44-32-1(b)	Research in literary, historical, or similar projects.
Post-Production	§ 44-18-30	Adaptation of existing business components.

Local Revenue Office Guidance and Administrative Rulings

The Rhode Island Division of Taxation has issued several pieces of guidance that clarify the interaction between the state credit and federal law. Most notably, Revenue Ruling 95-05 provides a definitive interpretation of the term “base period research expense.” At the time of the credit’s inception, federal law was transitioning in its terminology. The Tax Administrator ruled that “base period research expense” under R.I. Gen. Laws § 44-32-3 shall have the same meaning as the term “base amount” found in IRC § 41(c).

The Regular Method vs. ASC

A significant point of divergence between federal and state practice is the treatment of the Alternative Simplified Credit (ASC). While the federal government allows taxpayers to use the ASC method (which does not require gross receipts data and uses a three-year rolling average), Rhode Island does not recognize the ASC for state-level calculations. Taxpayers must use the “Regular Method” on Form RI-7695E, which requires determining the federal base amount. This means companies that do not track the historical gross receipts or base period data required for the federal regular credit may find it more difficult to document their Rhode Island claim, even if they use the ASC at the federal level.

Geographic Apportionment of Federal Excess

Form RI-7695E requires a precise apportionment of the taxpayer’s “Federal Excess Expenses.” This is calculated by taking the federal QREs (from Federal Form 6765, line 5 or 20) and subtracting the federal base amount (from Federal Form 6765, line 8, 10, or 22). The resulting federal excess is then multiplied by the percentage of the research that was actually conducted in Rhode Island.

Revenue Ruling 95-05 illustrates that this apportionment is not based on a general business allocation factor, but rather on where the specific dollars of research were spent. For instance, if a company has $100,000 in federal excess and 100% of its research activities were in Rhode Island, it can apply the RI credit rates to the full $100,000. However, if that same company performed 50% of its research in Rhode Island and 50% in California, only $50,000 of the federal excess would be eligible for the Rhode Island tiered rates on Form RI-7695E.

Technical Commentary on Form RI-7695E Calculation

The structure of Form RI-7695E is designed to lead the taxpayer through the incremental calculation process. The form is divided into lines that reconcile the federal credit figures with state-specific limitations.

Line-by-Line Breakdown

• Line 1 & 2: These lines import the Federal Qualified Research Expenses and the Federal Base Amount directly from Federal Form 6765. This ensures that the state credit is built upon the same technical foundation as the federal claim.
• Line 3: Calculates the Federal Excess Expenses by subtracting the base amount from the current year QREs. This reinforces the “incremental” nature of the credit; companies are only rewarded for research spending that exceeds their established baseline.
• Line 4: This is the geographic nexus line. The taxpayer must identify the portion of the federal excess from Line 3 that was incurred specifically in Rhode Island after July 1, 1994.
• Line 5: Applies the tiered rates of 22.5% and 16.9%. The instruction for this line clarifies that the 22.5% rate applies to expenditures up to $111,111.00. This $111,111 figure is derived from the statutory cap of $25,000 on the first tier of the credit ($25,000 / 0.225 = $111,111).
• Line 6 & 7: These lines track the carryforward. The taxpayer adds any unused credit from the preceding seven years to the current year’s calculated credit.

Limitations on Credit Utilization

The Rhode Island R&D Expense Credit is subject to two primary caps: a tax liability limit and a corporate minimum tax floor. These limitations ensure that the credit provides a meaningful incentive while protecting the state’s baseline revenue.

The 50% Tax Liability Cap

R.I. Gen. Laws § 44-32-3(c) stipulates that the credit cannot reduce the tax due for the year by more than 50% of the tax liability that would otherwise be payable. This calculation is performed after all other available credits have been applied. This “net of credits” limitation makes the R&D Expense Credit one of the last incentives utilized in the Rhode Island tax stack. For taxpayers with multiple credits (such as the Investment Tax Credit or the Jobs Development Act credit), the 50% cap for R&D can become a significant bottleneck, frequently pushing credits into the carryforward period.

The Corporate Minimum Tax and the $400 Floor

For corporations, the credit cannot reduce the tax due below the statutory minimum fixed by § 44-11-2(e). For tax years 2024 and 2025, the Rhode Island corporate minimum tax is $400.00. This floor applies to both C-corporations and S-corporations. Even if a company has millions of dollars in R&D credits, it must still pay at least $400 annually to maintain its corporate standing in the state.

Carryforward Provisions

Any credit amount that cannot be used in the current year due to the 50% cap or the $400 minimum can be carried over for a maximum of seven (7) years. This is a significantly shorter window than the 20-year federal carryforward or the 15-year carryforward allowed in Massachusetts. Taxpayers must carefully monitor their credit buckets to ensure that the oldest credits are used first and that none are allowed to expire.

Ordering of Credits and Interaction with § 44-32-2

Rhode Island law provides for a specific hierarchy of credits that a taxpayer must follow when completing their return and Schedule B-CR. The order in which credits are applied is not optional; it is mandated by both statute and regulation.

The R&D Property Credit (§ 44-32-2)

Before claiming the R&D Expense Credit (Form RI-7695E), a taxpayer must first utilize any credits for R&D Property. Codified under § 44-32-2, this credit provides for a 10% deduction of the cost or other basis of tangible personal property, including buildings and structural components, that are acquired or constructed for R&D purposes.

The interaction between the property credit and the expense credit is a common source of confusion. The property credit applies to capitalized assets (which are depreciable under IRC § 167), whereas the expense credit applies to operational costs like wages and supplies. Because the property credit must be taken first, it often absorbs a portion of the tax liability, potentially further limiting the amount of expense credit that can be used under the 50% cap.

Mandatory Hierarchy

The Division of Taxation specifies the following sequence for research-related incentives:

1. Investment Tax Credit (§ 44-31-1): Generally provides a 4% to 10% credit for investment in tangible property.
2. R&D Property Credit (§ 44-32-2): The 10% credit for R&D facilities and equipment.
3. R&D Expense Credit (§ 44-32-3): The tiered credit for wages and supplies reported on Form RI-7695E.

Entity-Specific Reporting and Pass-Through Dynamics

The reporting mechanism for the R&D credit depends heavily on the taxpayer’s legal structure. While C-corporations claim the credit directly to offset their 7% net income tax, pass-through entities (PTEs) must distribute the credit to their owners.

Pass-Through Entities (S-Corps, Partnerships, LLCs)

For partnerships, joint ventures, and S-corporations, the credit is calculated at the entity level but is then “divided in the same manner as income.” The entity must provide each owner with their pro-rata share of the credit, typically reported on the Rhode Island Schedule K-1. The owners then apply the credit to their personal income tax (Chapter 30) or corporate tax liability.

For tax years beginning on or after January 1, 2024, pass-through entities can elect to pay tax at the entity level via RI Schedule PTE. This election is designed to help owners bypass the federal SALT deduction limit. When an entity makes this election, the R&D credit can still be generated and utilized, but the interplay between the 90% credit for taxes paid at the entity level and the R&D Expense Credit requires careful coordination on the owner’s personal return.

Consolidated Returns

Rhode Island has strict rules regarding the use of R&D credits within a consolidated corporate group. The credit allowed under § 44-32-3 is only allowed against the tax of the specific corporation included in the consolidated return that actually qualifies for the credit. It cannot be used to offset the tax of other corporations in the group, even if they are filing a single combined or consolidated Rhode Island return. This “separate entity” rule prevents companies from shifting R&D credits from a research-intensive subsidiary to a profitable retail or manufacturing subsidiary within the same corporate structure.

Specialized Provisions for the Insurance Industry

One of the more unique features of the Rhode Island R&D statute is its specific inclusion of research performed by property and casualty insurance companies. Under § 44-32-3(b)(2), qualified research expenses are expanded to include amounts expended for research into “methods and ways of preventing or reducing losses from fire and other perils.”

This provision is an outlier compared to federal IRC § 41, which typically requires research to be technological in nature and intended for a business component for sale or use in the taxpayer’s trade or business. By explicitly including fire and peril loss prevention research, Rhode Island encourages the insurance industry to invest in public safety innovations that might not otherwise meet the strict “hard science” requirements of federal law. These insurance companies claim the credit against the taxes imposed by Chapter 17.

Compliance, Audits, and Documentation Requirements

The Rhode Island Division of Taxation has the authority to audit R&D credit claims to ensure they meet both the federal technical standards and the state’s geographic requirements. For “by right” credits like the R&D Expense Credit, taxpayers do not need pre-approval, but they must provide all supporting documentation with their return.

Record Retention

Taxpayers are advised to maintain records for at least four years, although a longer period may be necessary if the credit is part of an ongoing carryforward bucket. Essential documentation includes:

• Project Narratives: Descriptions of the research projects that explicitly address the 4-part test.
• Time Tracking: Records showing the percentage of time employees spent on qualified research while physically present in Rhode Island.
• Supply Invoices: Evidence that supplies and materials were used for research purposes within the state.
• Federal Form 6765: The foundational document used to establish the base amount and total QREs.

Address Verification on Form RI-7695E

A distinctive feature of Form RI-7695E is the requirement to list the “Complete address(es) of Rhode Island location(s) where Research & Development Expenses were Incurred.” This allows the Division of Taxation to conduct site visits or cross-reference the research activity with other state databases, such as the Department of Labor and Training’s payroll records.

Comprehensive Illustrative Example

To clarify the mechanics of the credit, let us examine a hypothetical scenario involving “Ocean State Biotech,” a C-corporation headquartered in Warwick, Rhode Island.

Step 1: Establish Federal Baseline

Ocean State Biotech conducts its federal R&D calculation first. For the 2024 tax year, their figures are as follows:

• Total Federal QREs: $1,500,000
• Federal Base Amount: $1,000,000
• Federal Excess Expenses: $500,000

Step 2: Determine Rhode Island Nexus

The company has two research labs: one in Warwick, RI, and one in Cambridge, MA. An analysis of their payroll and supply costs shows that 60% of their research activity occurs in the Warwick lab.

• Rhode Island Portion of Federal Excess: $500,000 × 60% = $300,000

Step 3: Apply Tiered Rates on Form RI-7695E

The company enters $300,000 on Line 4 of Form RI-7695E. The calculation for Line 5 is performed as follows:

Expenditure Tier	Calculation	Credit Amount
First $111,111	$111,111 × 22.5%	$24,999.98
Amount over $111,111	($300,000 – $111,111) × 16.9%	$31,921.25
Total Current Credit	$24,999.98 + $31,921.25	$56,921.23

Step 4: Aggregate Available Credits

Ocean State Biotech has an unused R&D carryforward of $15,000 from 2022.

• Total Credit Available: $56,921.23 + $15,000 = $71,921.23

Step 5: Apply Liability Limitations

The company’s 2024 Rhode Island tax liability (Form RI-1120C, Line 11) is $100,000. They also have an Investment Tax Credit of $10,000.

1. Starting Tax Liability: $100,000
2. Minus Investment Tax Credit: $10,000
3. Remaining Tax Payable: $90,000
4. 50% Limitation Cap: $90,000 × 50% = $45,000

Step 6: Final Claim and Carryover

Ocean State Biotech can only use $45,000 of their $71,921.23 available credit this year.

• Credit Claimed on Schedule B-CR: $45,000
• Carryover to 2025: $71,921.23 – $45,000 = $26,921.23
• Net Tax Due: $90,000 – $45,000 = $45,000 (Which is above the $400 minimum)

Comparative Policy Context and Regional Competitiveness

Rhode Island’s R&D tax credit is part of a broader competitive landscape in New England. While the 22.5% initial rate is highly attractive, the state’s restrictive carryforward and liability caps create a distinct policy profile.

Comparison Metric	Rhode Island	Massachusetts	Connecticut
Primary Rate	22.5% (Tiered)	10% – 15%	6% – 13.2%
Carryforward	7 Years	15 Years	15 Years
Max Tax Offset	50%	75% above $25k	70%
ASC Option	No	Yes	Yes
Refundability	No	No (except Life Sci)	No

Rhode Island’s strategy appears to be one of “high impact, high turnover.” By offering a very high credit rate on the first $111,111 of excess spending, the state aggressively recruits and supports early-stage startups and lean research operations. However, for large, established pharmaceutical or defense firms with decades of tax liability, the 7-year carryforward period and 50% cap serve as a mechanism to limit the state’s total fiscal exposure to these large-scale claims.

Recent Administrative and Legislative Changes (2024-2025)

The 2024 and 2025 tax years have seen important administrative updates from the Rhode Island Division of Taxation that affect the filing of Form RI-7695E. These changes primarily involve the modernization of the tax filing system and the introduction of new schedules for pass-through entities.

Electronic Filing Mandate

Starting January 1, 2023, “larger business registrants” are required to use electronic means to file returns and remit taxes. This includes corporations with an annual liability of $5,000 or more or gross income over $100,000. For R&D-intensive firms, this means that Form RI-7695E and Schedule B-CR must be submitted through the state’s electronic portal or through certified software providers to ensure the credits are properly captured.

Decoupling from Federal § 174 Amortization

A major technical challenge for 2025 filings is the federal requirement to capitalize and amortize R&D expenses over five years under IRC Section 174 (as modified by the TCJA). Rhode Island has created Schedule 174A and Schedule HR1 to address the state’s decoupling from certain federal provisions. While the R&D Credit calculation on Form RI-7695E still relies on the expenses incurred during the year, the deduction taken for those same expenses on the state income tax return must be adjusted to account for the state’s specific amortization rules.

Final Thoughts

The Rhode Island Research and Development Expense Credit remains one of the state’s most potent tools for attracting and retaining innovation-led businesses. Through Form RI-7695E, the state provides a clear, albeit complex, path for taxpayers to monetize their investments in new products and processes. The integration of federal IRC Section 41 definitions provides a familiar baseline for tax directors, while the state-specific tiered rates and 50% liability cap reflect Rhode Island’s unique fiscal priorities.

For businesses operating in the Ocean State, successful utilization of this credit requires more than just technical research; it requires meticulous documentation of the geographic situs of expenses, a clear understanding of credit ordering rules, and proactive monitoring of the 7-year carryforward window. As Rhode Island continues to refine its tax code—evidenced by the 2024 PTE election updates and the 2025 decoupling schedules—Form RI-7695E will remain the essential nexus where the laboratory meets the balance sheet.